New FDA-approved drug for vision loss now available at Retina Health Center
Following a three-year year clinical study at Retina Health Center and other participating eye centers around the country, the FDA has approved the use of the injectable drug Lucentis for the treatment of diabetic macular edema. Diabetic macular edema occurs when fluid...